We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBKR:NASDAQInteractive Brokers Group, Inc. Analysis

Data as of 2026-04-09 - not real-time

$71.62

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Interactive Brokers is trading above its 20‑day and 200‑day simple moving averages while still sitting just shy of its 50‑day SMA, suggesting short‑term momentum but a potential near‑term ceiling. The RSI sits in the mid‑50s and the MACD histogram is positive, reinforcing a modest bullish bias despite a neutral overall trend. Volatility remains elevated at over 40% for the past month and a beta well above one points to heightened price swings, while trading volume has been on a downtrend, hinting at reduced liquidity support. Recent news of the crypto‑asset trading launch in the European Economic Area sparked a noticeable intraday rally, adding a catalyst for further upside.
Fundamentally, the firm delivers robust revenue growth of roughly 15% with exceptional gross and operating margins, a strong cash position exceeding $100 B, and a modest debt‑to‑equity ratio. The dividend payout is low at under 14% of earnings, making the dividend sustainable, and a discounted cash‑flow model implies a fair‑value upside of about 9‑10% relative to the current price. While the price‑to‑earnings multiple is well above the industry average, the combination of high profitability, cash generation, and modest upside suggests the stock is modestly undervalued and positioned for continued growth.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above short‑term moving averages with bullish MACD signal
  • Crypto‑asset launch providing immediate catalyst
  • Support level well below current price offering downside buffer

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth and high operating margins
  • Strong cash balance and low payout ratio supporting dividend sustainability
  • DCF‑derived fair‑value upside indicating modest undervaluation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent profitability and high ROE
  • Exposure to regulatory and market‑structure changes in capital markets
  • Elevated volatility and beta suggesting price swings over longer horizons

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin15.85%
P/E Ratio32.3
ROE23.51%
ROA2.47%
Debt/Equity124.33
P/B Ratio5.9
Op. Cash Flow$15.8B
Industry P/E17.2

Technical Analysis

TrendNeutral
RSI57.5
Support$63.02
Resistance$73.48
MA 20$67.59
MA 50$70.68
MA 200$66.74
MACDBullish
VolumeDecreasing
Fear & Greed Index83.55

Valuation

Fair Value$212.16
Target Price$78.44
Upside/Downside9.53%
GradeUndervalued
TypeGrowth
Dividend Yield0.44%

Risk Assessment

Beta1.83
Volatility41.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.